~~<i id='4824FC630D'><strike id='4824FC630D'><tt id='4824FC630D'><pre id='4824FC630D'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

author：Wikipedia 2025-10-02 13:14:19 - browse：4

Michel Pairet -- health business coverage from STAT — Michel Pairet Courtesy Boehringer Ingelheim

LONDON — At an event here last week, the German pharmaceutical firm Boehringer Ingelheim outlined the projects in its pipeline.

There was obesity and liver disease, and computational biology and oncology. Then respiratory and inflammatory diseases. And don’t forget mental illness and retinal health. Oh, it was also the day the company launched another Humira biosimilar.

In other words, there was a whole lot for the company to discuss as it works to promote its breadth and build partnerships with academic researchers and other companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Medicare slashes safety net hospital payments by nearly $1 billion

Wikipedia

entertainment

focus

knowledge

hotspot

leisure time

DemonstratorsgatherneartheTexasstatecapitolfollowingtheSupremeCourt'sdecisiontooverturnRoev.Wadein20

WSS

Updated Covid vaccine has 54% effectiveness, new study suggests

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

Florida officials tell state schools to teach AP Psychology 'in its entirety'

It costs an awful lot of money to give away a kidney

Florida officials tell state schools to teach AP Psychology 'in its entirety'

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Wikipedia

Wikipedia

Wikipedia

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

340B reform proposal comes out of Senate working group

Malaria cases in Florida and Texas: Here’s what you need to know

Pharma showers House GOP doctor with campaign cash

BioMarin wins approval for gene therapy to treat hemophilia A

Group behind ProMed defends move to subscription

Cancer drug shortages should be causing more outrage

A protest over insulin prices is seen as a fight for life

United colonoscopy coverage change 'may cost lives,' doctors say

Problems with a popular proposal to regulate AI in health care

entertainment

Readout LOUD: Venture capital, Gilead, and more M&A

Readout LOUD: Venture capital, Gilead, and more M&A

Why Novartis is going to walk from its acquisition of MorphoSys

What’s missing from the debate over nursing home staff minimums

A controversial new treatment promises to make little people taller

Chris Christie meets with Zelenskyy during Ukraine trip

focus

knowledge

hotspot

leisure time